| Name | N-(1H-Benzimidazol-2-yl)-3-nitrobenzamide |
|---|---|
| Synonyms |
1-Ethylthymin
1-ethyl-5-methyl-1H-pyrimidine-2,4-dione N-1H-benzimidazol-2-yl-3-nitrobenzamide 1-ethylthymine 1-Aethyl-5-methyl-1H-pyrimidin-2,4-dion 2,4(1H,3H)-Pyrimidinedione,1-ethyl-5-methyl 3-nitro-N-(1H-benzoimidazol-2-yl)-benzamide 1-ethyl-5-methyl-2,4(3H)-pyrimidindione N1-ethylthymine |
| Molecular Formula | C14H10N4O3 |
|---|---|
| Molecular Weight | 282.25400 |
| Exact Mass | 282.07500 |
| PSA | 107.09000 |
| LogP | 3.63060 |
|
~84%
301675-24-1 |
| Literature: GLAXOSMITHKLINE LLC; LAFRANCE, Louis, Vincent; LEBER, Jack, Dale; LI, Mei; VERMA, Sharad, Kumar Patent: WO2010/126922 A1, 2010 ; Location in patent: Page/Page column 18 ; WO 2010/126922 A1 |
|
~%
Detail
|
| Literature: Tularik, Inc Patent: US2003/144286 A1, 2003 ; |
|
~%
301675-24-1 |
| Literature: Powers, Jay P.; Li, Shyun; Jaen, Juan C.; Liu, Jinqian; Walker, Nigel P.C.; Wang, Zhulun; Wesche, Holger Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 11 p. 2842 - 2845 |
| Precursor 5 | |
|---|---|
| DownStream 0 | |